Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study

(2019) Maria Pina Dore et al.   Probiotics and Antimicrobial Proteins

Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials

(2019) Asma Kazemi et al.   CLINICAL NUTRITION

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis

(2018) Katsuyoshi Matsuoka et al.   DIGESTIVE DISEASES AND SCIENCES

Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?

(2018) Rosanna Satta et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

(2018) Alexander C. Ford et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines

(2016) Enrica Pessione et al.   Frontiers in Microbiology

Risk and Safety of Probiotics

(2015) Shira Doron et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of probiotic treatment withBifidobacterium longum 536for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial

(2015) Hiroyuki Tamaki et al.   Digestive Endoscopy

Quantitative Risk–Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease

(2015) William E. Bennett   DRUG SAFETY

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

(2015) Yasushi Yoshimatsu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

(2013) Koji Atarashi et al.   NATURE

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial

(2012) Nisha Mangalat et al.   PLoS One

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

(2011) S. Oliva et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Beneficial Effects of Probiotic Bifidobacterium and Galacto-Oligosaccharide in Patients with Ulcerative Colitis: A Randomized Controlled Study

(2011) Hideki Ishikawa et al.   DIGESTION

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism

(2011) Fang Yan et al.   JOURNAL OF CLINICAL INVESTIGATION

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

(2011) Signe Wildt et al.   Journal of Crohns & Colitis

Human nutrition, the gut microbiome and the immune system

(2011) Andrew L. Kau et al.   NATURE

Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn’s disease

(2010) H. Steed et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Probiotics

(2010) N. T. Williams   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

(2009) Erasmo Miele et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology